Related by context. Frequent words. (Click for all words.) 69 Phase 2a clinical 69 phase IIa 68 dose escalation trial 67 Phase IIa trial 67 Phase 2b study 67 Phase IIb clinical 67 Phase 2b trial 66 Phase 2a trial 66 Phase 2a 65 Phase 1b clinical 64 Phase IIa clinical 64 Phase 2b clinical 64 Phase IIb trial 63 Phase Ib 63 phase IIb 63 phase 2a 62 Phase 1b 62 Phase Ia 62 clinical trial 62 Phase 1b trial 62 dose escalation study 62 Phase III clinical 61 Phase III pivotal 61 Phase IIb 61 multiple ascending dose 60 Phase 1a 60 Phase IIa 60 pivotal Phase III 59 Phase III 59 multicenter clinical 59 randomized Phase III 59 ozarelix 59 Phase 2b 59 single ascending dose 58 confirmatory Phase III 58 axitinib 58 Clinical Trial Results 58 Phase II 58 HGS ETR1 58 Phase III clinical trials 57 metastatic renal cell carcinoma 57 Phase III Trial 56 clinical trials 56 Phase IIa clinical trials 56 dose cohorts 56 Phase III trials 56 pivotal Phase 56 maribavir 55 refractory Hodgkin lymphoma 55 randomized Phase 55 alvimopan 55 relapsed multiple myeloma 55 refractory multiple myeloma 55 elagolix 55 AVN# [001] 55 Investigational Device Exemption IDE 55 Cethrin 55 AVE# 55 pharmacokinetic studies 54 Atiprimod 54 LymphoStat B 54 placebo controlled randomized 54 Phase III randomized 54 IMGN# 54 Clavis Pharma 54 confirmatory Phase 3 54 Phenoptin 54 PXD# 54 vandetanib 54 transcriptase inhibitor NNRTI 54 double blind placebo 54 Clinical Study 54 Bronchitol 54 relapsing remitting multiple sclerosis 53 diagnosed multiple myeloma 53 BCX# 53 SPIRIT III 53 dose escalation 53 RG# [001] 53 multicenter study 53 ocrelizumab 53 TELCYTA 53 Torisel 53 randomized controlled clinical 53 placebo controlled 53 mCRC 53 ThermoDox ® 53 blinded placebo controlled 53 plus prednisone 53 TORISEL 53 CoFactor 53 velaglucerase alfa 53 ASA# 53 Completes Enrollment 53 teduglutide 53 IDX# 53 LIALDA 53 castration resistant prostate cancer 53 evaluable patients 53 active comparator 53 diabetic neuropathic pain